share_log

亚虹医药(688176.SH)发布半年度业绩,净亏损1.84亿元

Yahong Medicine (688176.SH) released its semi-annual performance, with a net loss of 0.184 billion yuan.

Zhitong Finance ·  Aug 28, 2024 12:36

Yahong Pharmaceutical (688176.SH) disclosed its semi-annual report for 2024, and the company achieved a revenue of 8,049 million yuan during the reporting period...

Zhitong Finance APP News, Yahong Pharmaceutical (688176.SH) disclosed its semi-annual report for 2024, and the company achieved a revenue of 80.49 million yuan, a year-on-year increase of 103,397.96%; the net loss attributable to the parent company was 0.184 billion yuan, a year-on-year narrowing. The non-recurring net loss was 0.197 billion yuan, a year-on-year narrowing; the basic earnings per share was -0.32 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment